Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson's disease complicated by OFF episodes: a phase 3, open-label study.
Jan KassubekStewart A FactorErnest BalaguerJohannes SchwarzKallol Ray ChaudhuriStuart H IsaacsonStacy WuCarmen Denecke MuhrJaime KulisevskyPublished in: Journal of neurology (2024)
SL-APO was generally well tolerated and efficacious over the long term as an on-demand treatment for OFF episodes in patients with PD.